文献速递抗栓抗凝管理药物不良反应与药物警戒

原代人肺泡芯片血栓模型用于评估治疗药物

Primary Human Lung Alveolus-on-a-chip Model of Intravascular Thrombosis for Assessment of Therapeutics.
PubMed 文献 · Clin Pharmacol Ther · 2017-07-14

研究构建了微流控人肺泡芯片,内衬原代人肺泡上皮并与内皮界面共培养,在全血流灌注下可定量分析炎症诱导血栓的器官级贡献。芯片重现体内血小板-内皮动态,并显示LPS经激活肺泡上皮间接刺激血管内血栓,而非直接作用于内皮;PAR-1拮抗剂可抑制内皮活化与血栓形成。

要点

  • 肺泡芯片在全血流下可定量分析炎症诱导血栓的器官级贡献
  • LPS经激活肺泡上皮间接刺激血管内血栓,非直接作用于内皮
  • PAR-1拮抗剂可抑制内皮活化与血栓形成,验证模型筛药能力

核心结论

  • 该微流控人肺泡芯片可重现体内血小板-内皮动态,并用于定量分析炎症诱导肺微血管血栓的器官级贡献。

研究设计与样本

  • 微流控肺泡芯片内衬原代人肺泡上皮,与内皮界面共培养,并在全血流灌注条件下进行实验。

主要发现

  • 芯片重现体内应答,包括血小板-内皮动态。
  • LPS内毒素通过激活肺泡上皮间接刺激血管内血栓,而非直接作用于内皮。
  • PAR-1拮抗剂可抑制内皮活化与血栓形成,显示模型可解析复杂应答并识别抗血栓药物。

临床怎么用

  • 可用于研究人肺血栓病理生理并推进药物开发。
  • 可作为评估抗血栓药物疗效与毒理学的体外人肺微血管模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pulmonary thrombosis is a significant cause of patient mortality; however, there are no effective in vitro models of thrombi formation in human lung microvessels that could also assess therapeutics and toxicology of antithrombotic drugs. Here, we show that a microfluidic lung alveolus-on-a-chip lined by human primary alveolar epithelium interfaced with endothelium and cultured under flowing whole blood can be used to perform quantitative analysis of organ-level contributions to inflammation-induced thrombosis. This microfluidic chip recapitulates in vivo responses, including platelet-endothelial dynamics and revealed that lipopolysaccharide (LPS) endotoxin indirectly stimulates intravascular thrombosis by activating the alveolar epithelium, rather than acting directly on endothelium. This model is also used to analyze inhibition of endothelial activation and thrombosis due to a protease activated receptor-1 (PAR-1) antagonist, demonstrating its ability to dissect complex responses and identify antithrombotic therapeutics. Thus, this methodology offers a new approach to study human pathophysiology of pulmonary thrombosis and advance drug development.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Jain A, Barrile R, van der Meer AD, et al. Primary Human Lung Alveolus-on-a-chip Model of Intravascular Thrombosis for Assessment of Therapeutics. Clin Pharmacol Ther. 2017. PMID: 28516446. doi:10.1002/cpt.742

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。